Funding for this research was provided by:
Institut National Du Cancer (#RECF1764)
Text and Data Mining valid from 2018-04-03
Received: 21 August 2017
Accepted: 20 March 2018
First Online: 3 April 2018
Ethics approval and consent to participate
: The protocol of the ALTAK study (NCT01647425) was declared to and approved by the Comité de Protection des Personnes Nord-Ouest (#CPP12/09) and the Agence Nationale des Médicaments et produits de santé (#B111675–10). All participants gave their written consent for participating in the study.
: Not Applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.